» Articles » PMID: 38420127

Identification of Platelet-related Subtypes and Diagnostic Markers in Pediatric Crohn's Disease Based on WGCNA and Machine Learning

Overview
Journal Front Immunol
Date 2024 Feb 29
PMID 38420127
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The incidence of pediatric Crohn's disease (PCD) is increasing worldwide every year. The challenges in early diagnosis and treatment of PCD persist due to its inherent heterogeneity. This study's objective was to discover novel diagnostic markers and molecular subtypes aimed at enhancing the prognosis for patients suffering from PCD.

Methods: Candidate genes were obtained from the GSE117993 dataset and the GSE93624 dataset by weighted gene co-expression network analysis (WGCNA) and differential analysis, followed by intersection with platelet-related genes. Based on this, diagnostic markers were screened by five machine learning algorithms. We constructed predictive models and molecular subtypes based on key markers. The models were evaluated using the GSE101794 dataset as the validation set, combined with receiver operating characteristic curves, decision curve analysis, clinical impact curves, and calibration curves. In addition, we performed pathway enrichment analysis and immune infiltration analysis for different molecular subtypes to assess their differences.

Results: Through WGCNA and differential analysis, we successfully identified 44 candidate genes. Following this, employing five machine learning algorithms, we ultimately narrowed it down to five pivotal markers: GNA15, PIK3R3, PLEK, SERPINE1, and STAT1. Using these five key markers as a foundation, we developed a nomogram exhibiting exceptional performance. Furthermore, we distinguished two platelet-related subtypes of PCD through consensus clustering analysis. Subsequent analyses involving pathway enrichment and immune infiltration unveiled notable disparities in gene expression patterns, enrichment pathways, and immune infiltration landscapes between these subtypes.

Conclusion: In this study, we have successfully identified five promising diagnostic markers and developed a robust nomogram with high predictive efficacy. Furthermore, the recognition of distinct PCD subtypes enhances our comprehension of potential pathogenic mechanisms and paves the way for future prospects in early diagnosis and personalized treatment.

Citing Articles

Artificial intelligence use for precision medicine in inflammatory bowel disease: a systematic review.

Ceccato H, Silva T, Genaro L, Silva J, de Souza W, Oliveira P Am J Transl Res. 2025; 17(1):28-46.

PMID: 39959235 PMC: 11826164. DOI: 10.62347/XILL3707.

References
1.
Schmitt H, Neurath M, Atreya R . Role of the IL23/IL17 Pathway in Crohn's Disease. Front Immunol. 2021; 12:622934. PMC: 8042267. DOI: 10.3389/fimmu.2021.622934. View

2.
Mezynski M, Farrelly A, Cremona M, Carr A, Morgan C, Workman J . Targeting the PI3K and MAPK pathways to improve response to HER2-targeted therapies in HER2-positive gastric cancer. J Transl Med. 2021; 19(1):184. PMC: 8088633. DOI: 10.1186/s12967-021-02842-1. View

3.
El Bannoudi H, Cornwell M, Luttrell-Williams E, Engel A, Rolling C, Barrett T . Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus. Arthritis Rheumatol. 2022; 75(5):711-722. DOI: 10.1002/art.42382. View

4.
Hanzelmann S, Castelo R, Guinney J . GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013; 14:7. PMC: 3618321. DOI: 10.1186/1471-2105-14-7. View

5.
Timmermans W, van Laar J, van der Houwen T, Kamphuis L, Bartol S, Lam K . B-Cell Dysregulation in Crohn's Disease Is Partially Restored with Infliximab Therapy. PLoS One. 2016; 11(7):e0160103. PMC: 4965034. DOI: 10.1371/journal.pone.0160103. View